Catalent
CTLT
#1598
Rank
ยฃ8.47 B
Marketcap
ยฃ46.68
Share price
0.00%
Change (1 day)
46.24%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Revenue for Catalent (CTLT)

Revenue in 2024 (TTM): ยฃ3.48 Billion

According to Catalent's latest financial reports the company's current revenue (TTM ) is ยฃ3.46 Billion. In 2023 the company made a revenue of ยฃ3.21 Billion a decrease over the revenue in the year 2022 that were of ยฃ3.93 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Catalent from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ3.48 B8.43%
2023 ยฃ3.21 B-18.19%
2022 ยฃ3.93 B18.39%
2021 ยฃ3.32 B30.65%
2020 ยฃ2.54 B22.14%
2019 ยฃ2.08 B6.19%
2018 ยฃ1.96 B15.19%
2017 ยฃ1.70 B10.73%
2016 ยฃ1.53 B24.13%
2015 ยฃ1.23 B4.37%
2014 ยฃ1.18 B8.27%
2013 ยฃ1.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.49 B-85.62%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.16 B-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.09 B-10.75%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ0.25 B-92.75%๐Ÿ‡บ๐Ÿ‡ธ USA